TSS
BDSX icon

Two Sigma Securities’s Biodesix BDSX Stock Holding History

Two Sigma Securities’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-553
Closed -$16.9K – 2867
2024
Q2 		$16.9K Buy
+553
New +$15.8K ﹤0.01% 2732
2022
Q3 		– Sell
-658
Closed -$22K – 2602
2022
Q2 		$22K Buy
+658
New +$21.4K ﹤0.01% 1943

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Two Sigma Securities's BDSX Position: Q3 2024 in Review

Two Sigma Securities sold out of Biodesix (BDSX) in Q3 2024, closing a stake of 553 shares — an estimated $16.9K sold.

Two Sigma Securities first reported a position in BDSX in Q2 2022 and held it in 2 quarters. The position peaked at $22K in Q2 2022. 52 funds tracked by Wall St. Rank hold BDSX as of Q3 2024.

  • Two Sigma Securities reported no remaining Biodesix position as of Q3 2024 after selling out during the quarter.
  • Two Sigma Securities sold 553 Biodesix shares in Q3 2024, an estimated $16.9K.
  • Two Sigma Securities first reported a position in Biodesix in Q2 2022 and held it in 2 quarters.
  • Two Sigma Securities's Biodesix position peaked at $22K in Q2 2022.
  • 52 funds tracked by Wall St. Rank held Biodesix as of Q3 2024.

Based on Two Sigma Securities's 13F filing for Q3 2024, filed 14 Nov 2024.